Please login to the form below
voclosporin
This page shows the latest voclosporin news and features for those working in and with pharma, biotech and healthcare.
Lupus trial hailed as a success despite patient deaths
Lupus trial hailed as a success despite patient deaths. Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective. ... The phase IIb trial of Aurinia Pharmaceuticals' voclosporin met its objective of improving complete remission rates
Latest news
-
Scratching the surface
The ESSENCE and SPIRIT trials have been completed for Isotechnika's voclosporin, a calcineurin inhibitor and oral immunosuppressant. ... The likelihood of voclosporin gaining approval is 58 per cent, according to inThought analysts.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Bayer veteran joins Aurinia as CEO
Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said. ... companies. “ He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution.".
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- MaxCyte gets green light for solid tumour cell therapy
- Brexit rebels win vote on European Medicines Agency alignment
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
- Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
PMHub
Adelphi Research UK
Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
